Literature DB >> 32358233

Extracorporeal Life Support Organization COVID-19 Interim Guidelines.

Kiran Shekar1, Jenelle Badulak, Giles Peek2, Udo Boeken3, Heidi J Dalton4, Lovkesh Arora5, Bishoy Zakhary6, Kollengode Ramanathan7, Joanne Starr8, Bindu Akkanti9, M Velia Antonini10, Mark T Ogino11, Lakshmi Raman12.   

Abstract

Year:  2020        PMID： 32358233      PMCID： PMC7228451          DOI： 10.1097/MAT.0000000000001193

Source DB:  PubMed          Journal:  ASAIO J        ISSN： 1058-2916            Impact factor:   2.872


× No keyword cloud information.
  74 in total

Review 1.  Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.

Authors:  Julie M Varghese; Jason A Roberts; Jeffrey Lipman
Journal:  Crit Care Clin       Date:  2011-01       Impact factor: 3.598

Review 2.  Management of refractory cardiogenic shock.

Authors:  Alex Reyentovich; Maya H Barghash; Judith S Hochman
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

3.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

4.  Position paper for the organization of ECMO programs for cardiac failure in adults.

Authors:  Darryl Abrams; A Reshad Garan; Akram Abdelbary; Matthew Bacchetta; Robert H Bartlett; James Beck; Jan Belohlavek; Yih-Sharng Chen; Eddy Fan; Niall D Ferguson; Jo-Anne Fowles; John Fraser; Michelle Gong; Ibrahim F Hassan; Carol Hodgson; Xiaotong Hou; Katarzyna Hryniewicz; Shingo Ichiba; William A Jakobleff; Roberto Lorusso; Graeme MacLaren; Shay McGuinness; Thomas Mueller; Pauline K Park; Giles Peek; Vin Pellegrino; Susanna Price; Erika B Rosenzweig; Tetsuya Sakamoto; Leonardo Salazar; Matthieu Schmidt; Arthur S Slutsky; Christian Spaulding; Hiroo Takayama; Koji Takeda; Alain Vuylsteke; Alain Combes; Daniel Brodie
Journal:  Intensive Care Med       Date:  2018-02-15       Impact factor: 17.440

Review 5.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.

Authors:  Jason Phua; Li Weng; Lowell Ling; Moritoki Egi; Chae-Man Lim; Jigeeshu Vasishtha Divatia; Babu Raja Shrestha; Yaseen M Arabi; Jensen Ng; Charles D Gomersall; Masaji Nishimura; Younsuck Koh; Bin Du
Journal:  Lancet Respir Med       Date:  2020-04-06       Impact factor: 30.700

Review 6.  Triage: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.

Authors:  Michael D Christian; Charles L Sprung; Mary A King; Jeffrey R Dichter; Niranjan Kissoon; Asha V Devereaux; Charles D Gomersall
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

Review 7.  Nutrition therapy in critical illness: a review of the literature for clinicians.

Authors:  Kate J Lambell; Oana A Tatucu-Babet; Lee-Anne Chapple; Dashiell Gantner; Emma J Ridley
Journal:  Crit Care       Date:  2020-02-04       Impact factor: 9.097

Review 8.  Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO.

Authors:  Alberto Zangrillo; Giuseppe Biondi-Zoccai; Giovanni Landoni; Giacomo Frati; Nicolò Patroniti; Antonio Pesenti; Federico Pappalardo
Journal:  Crit Care       Date:  2013-02-13       Impact factor: 9.097

9.  COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; Silvia Coppola; Massimo Cressoni; Mattia Busana; Sandra Rossi; Davide Chiumello
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

10.  Initiation of a new infection control system for the COVID-19 outbreak.

Authors:  Xuejiao Chen; Junzhang Tian; Guanming Li; Guowei Li
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.